---

widget: portfolio 

headless: true 

weight: 20 

title: Welcome!

design:
  columns: '2'
  view: 5
  css_style:
  css_class:
  
---

<br>

**Ryan Group** is interested in how gene loss rewires tumour cells and how this may be exploited to target them therapeutically. A particular focus of the group is the identification of synthetic lethality - a phenomenon whereby mutation of one gene renders tumour cells especially sensitive to the perturbation of a second gene.
